728. Do Probiotics Prevent Nosocomial Infection? NO
Session: Interactive Session: Clinical Controversies in Infectious Diseases
Friday, October 21, 2011: 2:35 PM
Room: Grand Ballroom (East-West)


David Snydman, MD, FIDSA, Tufts-New England Medical Center, Boston, MA

David R. Snydman, MD, FACP, FIDSA is the Chief of the Division of Geographic Medicine and Infectious Diseases and Hospital Epidemiologist at Tufts Medical Center and Professor of Medicineat Tufts University School of Medicine and Professor of Medicine in the Sackler School of Graduate Medical Education. He is board certified in medicine and infectious diseases. Dr. Snydman has been involved in clinical research for over 30 years. He developed Cytomegalovirus Immune Globulin, brought it to licensure and was awarded a citation from the Massachusetts Department of Public Health for his efforts. He also has elucidated the relationship between CMV and adverse outcomes associated with organ transplantation. Dr. Snydman has been a Teaching and Research scholar of the American College of Physicians. He was awarded the Natalie V. and Milton O. Zucker prize from Tufts University School of Medicine for his research on viral infections in transplantation, and has been awarded the Ken Kaplan Clinician award from the Massachusetts chapter of the Infectious Disease Society of America. In 2004 he was given a Distinguished Faculty Award from Tufts University School of Medicine. He has published over 300 peer reviewed original articles, book chapters and reviews, and edited or co-edited 20 books. He is on the editorial board of Transplantation, is the section editor for Clinical Infectious Diseases for immunocompromised hosts other than HIV, and is on the editorial board of the Mayo Clinic Proceedings. Current research interests include the use of probiotics in compromised hosts.



Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.